NCT00207051 BMS-582664 in Combination With Erbitux in Patients With Advanced Gastrointestinal Malignancies Status COMPLETED Phase PHASE1
NCT00207025 A Phase I Study of BMS-275183 Given on a Daily Schedule in Patients With Advanced Malignancies Status TERMINATED Phase PHASE1
NCT00205660 Changes in Adiposity, Metabolic Measures From Atypicals to Aripiprazole Status COMPLETED Phase PHASE4
NCT00203931 Trial Comparing Cetuximab With Pemetrexed/Cetuximab Therapy for Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT00198302 Clinical Trial Comparing Safety and Pharmacokinetics of Standard Antibiotic Therapy, Plus Aurexis® or Placebo, for Treatment of Staphylococcus Aureus Bacteremia (SAB) Status COMPLETED Phase PHASE2
NCT00198289 Aurexis® in Cystic Fibrosis Subjects Chronically Colonized With Staphylococcus Aureus in Their Lungs Status COMPLETED Phase PHASE2
NCT00198055 A Study of Aripiprazole in Children and Adolescents With Aspergers and Pervasive Developmental Disorder. Status COMPLETED Phase PHASE2
NCT00197613 The Adult Antiretroviral Treatment and Resistance Study (Tshepo) Status COMPLETED Phase PHASE3
NCT00196612 Once Daily Antiretroviral Therapy in HIV Infected Adults Treated With HAART Status COMPLETED Phase PHASE3
NCT00196599 Pilot Study on Once Daily FTC, ddI, Efavirenz Combination in Antiretroviral Naive HIV Infected Adults Status COMPLETED Phase PHASE2
NCT00194753 Adjuvant Therapy for High-Risk Breast Cancer With Wkly Adriamycin & Oral Cytoxan With G-CSF for 12 Wks; Wkly Taxol x 12 Status COMPLETED Phase PHASE2
NCT00194077 Study of Aripiprazole (Abilify) in Children With Symptoms of Mania Status COMPLETED Phase PHASE3
NCT00194012 Study of Aripiprazole (Abilify) Versus Placebo in Children With Subsyndromal Bipolar Disorder Status COMPLETED Phase PHASE3
NCT00193531 Paclitaxel, Carboplatin, and Oral Etoposide Followed by Weekly Paclitaxel in High Grade Neuroendocrine Carcinoma Status COMPLETED Phase PHASE2
NCT00193453 Gemcitabine, Docetaxel, and Cetuximab in Patients With Unresectable Advanced Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00193310 Preoperative or Postoperative Therapy of Patients With Stages IB, II, IIIA Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00193219 Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2